Media-OutReach Newswire Wegovy® (semaglutide 2.4mg) by Novo Nordisk is now Available in Singapore for Weight Management
Media-OutReach Newswire Health2Sync and Novo Nordisk Pharma Korea, Ltd. Launch Smart Cap Mallya® for FlexTouch® Insulin Pens Integration in South Korea, Enhancing insulin administration via Digital Diabetes Care
Media-OutReach Newswire Rethinking Obesity: Novo Nordisk’s Latest Initiative Urges Singaporeans to Treat, Not Blame
Media-OutReach Newswire Zuellig Pharma Launches Lilly’s Innovative Obesity and Diabetes Medicine in Thailand
Media-OutReach Newswire Prudential partners Thomson Medical Centre to offer more healthcare options and convenience for customers
Media-OutReach Newswire Diabetes Association Unveils T-CaReMe Taipei Declaration at the Asia Diabetes International Conference
Media-OutReach Newswire Case Study Highlights INDIBA 448 kHz Radiofrequency’s Role in Visceral Fat Reduction and Prevention of Fat Accumulation
Media-OutReach Newswire Health2Sync Completes an Oversubscribed Round of US$20 Million to Fuel Market Expansion and Prepares for Public Listing
Media-OutReach Newswire Health2Sync Deepens Reach and Partnerships in South Korea with Growing Adoption of its Digital Disease Management Platform